{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:47:14Z","timestamp":1793296034053,"version":"4.5.0"},"reference-count":105,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["106665"],"award-info":[{"award-number":["106665"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.cbi.2018.12.004","type":"journal-article","created":{"date-parts":[[2018,12,10]],"date-time":"2018-12-10T14:07:18Z","timestamp":1544450838000},"page":"140-150","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"special_numbering":"C","title":["Subterminal hydroxyeicosatetraenoic acids: Crucial lipid mediators in normal physiology and disease states"],"prefix":"10.1016","volume":"299","author":[{"given":"Sherif M.","family":"Shoieb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5286-8878","authenticated-orcid":false,"given":"Ahmed A.","family":"El-Sherbeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayman O.S.","family":"El-Kadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2018.12.004_bib1","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2174\/1389200043335540","article-title":"Cytochrome P450 in neurological disease","volume":"5","author":"Liu","year":"2004","journal-title":"Curr. Drug Metabol."},{"key":"10.1016\/j.cbi.2018.12.004_bib2","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1152\/physrev.00021.2001","article-title":"P-450 metabolites of arachidonic acid in the control of cardiovascular function","volume":"82","author":"Roman","year":"2002","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.cbi.2018.12.004_bib3","doi-asserted-by":"crossref","first-page":"e0144","DOI":"10.1199\/tab.0144","article-title":"Cytochromes p450","volume":"9","author":"Bak","year":"2011","journal-title":"Arabia B"},{"key":"10.1016\/j.cbi.2018.12.004_bib4","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2000-1-6-reviews3003","article-title":"Cytochromes P450: a success story","volume":"1","author":"Werck-Reichhart","year":"2000","journal-title":"Genome Biol."},{"key":"10.1016\/j.cbi.2018.12.004_bib5","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.yapd.2016.04.011","article-title":"Docosahexaenoic acid and arachidonic acid nutrition in early development","volume":"63","author":"Carlson","year":"2016","journal-title":"Adv. Pediatr."},{"key":"10.1016\/j.cbi.2018.12.004_bib6","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.prostaglandins.2016.07.009","article-title":"An insight into the role of arachidonic acid derived lipid mediators in virus associated pathogenesis and malignancies","volume":"126","author":"Chandrasekharan","year":"2016","journal-title":"Prostag. Other Lipid Mediat."},{"key":"10.1016\/j.cbi.2018.12.004_bib7","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/978-3-319-16009-2_6","article-title":"Cytochrome p450 enzymes in the bioactivation of polyunsaturated Fatty acids and their role in cardiovascular disease","volume":"851","author":"Westphal","year":"2015","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.cbi.2018.12.004_bib8","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1126\/science.294.5548.1871","article-title":"Prostaglandins and leukotrienes: advances in eicosanoid biology","volume":"294","author":"Funk","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.cbi.2018.12.004_bib9","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/bs.apha.2015.05.002","article-title":"Cytochrome P450 \u03c9-hydroxylases in inflammation and cancer","volume":"74","author":"Johnson","year":"2015","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.cbi.2018.12.004_bib10","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev.biochem.69.1.145","article-title":"Cyclooxygenases: structural, cellular, and molecular biology","volume":"69","author":"Smith","year":"2000","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.cbi.2018.12.004_bib11","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1161\/ATVBAHA.110.207449","article-title":"Prostaglandins and inflammation","volume":"31","author":"Ricciotti","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.cbi.2018.12.004_bib12","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/nature01320","article-title":"Points of control in inflammation","volume":"420","author":"Nathan","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.cbi.2018.12.004_bib13","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.alit.2014.09.001","article-title":"The role of leukotrienes in allergic diseases","volume":"64","author":"Liu","year":"2015","journal-title":"Allergol. Int."},{"key":"10.1016\/j.cbi.2018.12.004_bib14","doi-asserted-by":"crossref","first-page":"5866","DOI":"10.1021\/cr200246d","article-title":"Lipoxygenase and leukotriene pathways: biochemistry, biology, and roles in disease","volume":"111","author":"Haeggstr\u00f6m","year":"2011","journal-title":"Chem. Rev."},{"key":"10.1016\/j.cbi.2018.12.004_bib15","series-title":"Cytochrome P450","year":"2005"},{"key":"10.1016\/j.cbi.2018.12.004_bib16","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1096\/fasebj.6.2.1537463","article-title":"Cytochrome P450 and the arachidonate cascade","volume":"6","author":"Capdevila","year":"1992","journal-title":"Faseb. J."},{"key":"10.1016\/j.cbi.2018.12.004_bib17","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.bbalip.2014.10.008","article-title":"Biosynthesis, biological effects, and receptors of hydroxyeicosatetraenoic acids (HETEs) and oxoeicosatetraenoic acids (oxo-ETEs) derived from arachidonic acid","volume":"1851","author":"Powell","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.cbi.2018.12.004_bib18","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.addr.2011.03.006","article-title":"The roles of CYP450 epoxygenases and metabolites, epoxyeicosatrienoic acids, in cardiovascular and malignant diseases","volume":"63","author":"Xu","year":"2011","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.cbi.2018.12.004_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/03602532.2016.1257021","article-title":"Microsomal cytochrome P450 as a target for drug discovery and repurposing","volume":"49","author":"El-Sherbeni","year":"2017","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.cbi.2018.12.004_bib20","doi-asserted-by":"crossref","first-page":"11809","DOI":"10.1021\/ja026872d","article-title":"What factors affect the regioselectivity of oxidation by cytochrome p450? A DFT study of allylic hydroxylation and double bond epoxidation in a model reaction","volume":"124","author":"de Visser","year":"2002","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.cbi.2018.12.004_bib21","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1111\/j.1476-5381.2009.00461.x","article-title":"3-methylcholanthrene and benzo(a)pyrene modulate cardiac cytochrome P450 gene expression and arachidonic acid metabolism in male Sprague Dawley rats","volume":"158","author":"Aboutabl","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.cbi.2018.12.004_bib22","first-page":"473","article-title":"Concerning cytochromes P450: role in the metabolism and toxicity of drugs and other xenobiotics","volume":"vol. 4","author":"Ingelman-Sundberg","year":"2009"},{"key":"10.1016\/j.cbi.2018.12.004_bib23","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1124\/dmd.114.057836","article-title":"Characterization of arachidonic acid metabolism by rat cytochrome P450 enzymes: the involvement of CYP1As","volume":"42","author":"El-Sherbeni","year":"2014","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.cbi.2018.12.004_bib24","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/j.bcp.2003.12.023","article-title":"Arachidonic and eicosapentaenoic acid metabolism by human CYP1A1: highly stereoselective formation of 17(R),18(S)-epoxyeicosatetraenoic acid","volume":"67","author":"Schwarz","year":"2004","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2018.12.004_bib25","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/ddr.20040","article-title":"Cytochrome P450 structures and their substrate interactions","volume":"66","author":"V Lewis","year":"2006","journal-title":"Drug. Dev. Res. Drug. Dev. Res."},{"key":"10.1016\/j.cbi.2018.12.004_bib26","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1021\/acs.molpharmaceut.5b00873","article-title":"Repurposing resveratrol and fluconazole to modulate human cytochrome P450-mediated arachidonic acid metabolism","volume":"13","author":"El-Sherbeni","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.cbi.2018.12.004_bib27","first-page":"R1691","article-title":"Kinetic profile of the rat CYP4A isoforms: arachidonic acid metabolism and isoform-specific inhibitors","volume":"276","author":"Nguyen","year":"1999","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.cbi.2018.12.004_bib28","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1517\/17425255.4.8.1053","article-title":"Advances in the interpretation and prediction of CYP2E1 metabolism from a biochemical perspective","volume":"4","author":"Miller","year":"2008","journal-title":"Expert Opin. Drug Metabol. Toxicol."},{"key":"10.1016\/j.cbi.2018.12.004_bib29","doi-asserted-by":"crossref","first-page":"12912","DOI":"10.1016\/S0021-9258(18)31472-8","article-title":"Formation of 19(S)-, 19(R)-, and 18(R)-hydroxyeicosatetraenoic acids by alcohol-inducible cytochrome P450 2E1","volume":"268","author":"Laethem","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2018.12.004_bib30","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1006\/abbi.1998.0806","article-title":"Cloning and expression of murine CYP2Cs and their ability to metabolize arachidonic acid","volume":"357","author":"Luo","year":"1998","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.cbi.2018.12.004_bib31","doi-asserted-by":"crossref","first-page":"25467","DOI":"10.1074\/jbc.M100545200","article-title":"Cytochrome P450 CYP2J9, a new mouse arachidonic acid omega-1 hydroxylase predominantly expressed in brain","volume":"276","author":"Qu","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2018.12.004_bib32","doi-asserted-by":"crossref","first-page":"6305","DOI":"10.1074\/jbc.M311830200","article-title":"CYP2U1, a novel human thymus- and brain-specific cytochrome P450, catalyzes omega- and (omega-1)-hydroxylation of fatty acids","volume":"279","author":"Chuang","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2018.12.004_bib33","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.bcp.2013.11.015","article-title":"Alterations in cytochrome P450-derived arachidonic acid metabolism during pressure overload-induced cardiac hypertrophy","volume":"87","author":"El-Sherbeni","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2018.12.004_bib34","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.taap.2015.10.003","article-title":"19-Hydroxyeicosatetraenoic acid and isoniazid protect against angiotensin II-induced cardiac hypertrophy","volume":"289","author":"Elkhatali","year":"2015","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.cbi.2018.12.004_bib35","first-page":"R863","article-title":"Cytochrome P-450-dependent HETEs: profile of biological activity and stimulation by vasoactive peptides","volume":"271","author":"Carroll","year":"1996","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.cbi.2018.12.004_bib36","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3390\/pharmaceutics9010009","article-title":"Clinical implications of 20-hydroxyeicosatetraenoic acid in the kidney, liver, lung and brain: an emerging therapeutic target","volume":"9","author":"Elshenawy","year":"2017","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.cbi.2018.12.004_bib37","doi-asserted-by":"crossref","first-page":"F949","DOI":"10.1152\/ajprenal.2000.278.6.F949","article-title":"Effects of 20-HETE and 19( S )-HETE on rabbit proximal straight tubule volume transport","volume":"278","author":"Quigley","year":"2000","journal-title":"Am. J. Physiol. Physiol."},{"key":"10.1016\/j.cbi.2018.12.004_bib38","first-page":"161","article-title":"Biosynthesis of 20-hydroxyeicosatetraenoic acid (20-HETE) and 12 (S)-HETE by renal cortical microsomes of the cynomolgus monkey","volume":"3","author":"Oliw","year":"1990","journal-title":"Eicosanoids"},{"key":"10.1016\/j.cbi.2018.12.004_bib39","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1124\/jpet.104.070979","article-title":"Transfection and functional expression of CYP4A1 and CYP4A2 using bicistronic vectors in vascular cells and tissues","volume":"311","author":"Wang","year":"2004","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.cbi.2018.12.004_bib40","doi-asserted-by":"crossref","first-page":"F51","DOI":"10.1152\/ajprenal.00249.2002","article-title":"Transfection of CYP4A1 cDNA increases vascular reactivity in renal interlobar arteries","volume":"284","author":"Kaide","year":"2003","journal-title":"Am. J. Physiol. Physiol."},{"key":"10.1016\/j.cbi.2018.12.004_bib41","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1124\/jpet.104.070797","article-title":"P2X receptor-stimulated calcium responses in preglomerular vascular smooth muscle cells involves 20-hydroxyeicosatetraenoic acid","volume":"311","author":"Zhao","year":"2004","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.cbi.2018.12.004_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/CRD.0b013e3182961659","article-title":"20-HETE and blood pressure regulation: clinical implications","volume":"22","author":"Wu","year":"2014","journal-title":"Cardiol. Rev."},{"key":"10.1016\/j.cbi.2018.12.004_bib43","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1161\/01.RES.83.11.1069","article-title":"Nitric oxide-20-hydroxyeicosatetraenoic acid interaction in the regulation of K+ channel activity and vascular tone in renal arterioles","volume":"83","author":"Sun","year":"1998","journal-title":"Circ. Res."},{"key":"10.1016\/j.cbi.2018.12.004_bib44","first-page":"F790","article-title":"20-HETE agonists and antagonists in the renal circulation","volume":"277","author":"Alonso-Galicia","year":"1999","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.cbi.2018.12.004_bib46","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S0006-291X(88)80422-4","article-title":"19(S)-hydroxyeicosatetraenoic acid is a potent stimulator of renal Na+-K+-ATPase","volume":"152","author":"Escalante","year":"1988","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cbi.2018.12.004_bib47","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1161\/01.HYP.0000150782.28485.91","article-title":"Decreased levels of cytochrome P450 2E1-derived eicosanoids sensitize renal arteries to constrictor agonists in spontaneously hypertensive rats","volume":"45","author":"Zhang","year":"2005","journal-title":"Hypertension (Dallas, Tex. 1979)"},{"key":"10.1016\/j.cbi.2018.12.004_bib48","doi-asserted-by":"crossref","first-page":"H1018","DOI":"10.1152\/ajpheart.01172.2007","article-title":"20-Hydroxyeicosatetraenoic acid causes endothelial dysfunction via eNOS uncoupling","volume":"294","author":"Cheng","year":"2008","journal-title":"Am. J. Physiol. Circ. Physiol."},{"key":"10.1016\/j.cbi.2018.12.004_bib49","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/00000441-199403000-00003","article-title":"Tin-mediated heme oxygenase gene activation and cytochrome P450 arachidonate hydroxylase inhibition in spontaneously hypertensive rats","volume":"307","author":"Da Silva","year":"1994","journal-title":"Am. J. Med. Sci."},{"key":"10.1016\/j.cbi.2018.12.004_bib50","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1172\/JCI114686","article-title":"Effect of heme arginate administration on blood pressure in spontaneously hypertensive rats","volume":"86","author":"Levere","year":"1990","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cbi.2018.12.004_bib51","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.thromres.2016.06.031","article-title":"Relationship between metabolites of arachidonic acid and prognosis in patients with acute coronary syndrome","volume":"144","author":"Zu","year":"2016","journal-title":"Thromb. Res."},{"key":"10.1016\/j.cbi.2018.12.004_bib52","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.prostaglandins.2014.08.002","article-title":"Urinary CYP eicosanoid excretion correlates with glomerular filtration in African-Americans with chronic kidney disease","volume":"113\u2013115","author":"Dreisbach","year":"2014","journal-title":"Prostag. Other Lipid Mediat."},{"key":"10.1016\/j.cbi.2018.12.004_bib53","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1097\/FPC.0000000000000009","article-title":"Sex differences in the effect of cytochrome P450 2C19 polymorphisms on the risk of diabetic retinopathy: a retrospective longitudinal study in Japanese patients with type 2 diabetes","volume":"23","author":"Kajiwara","year":"2013","journal-title":"Pharmacogenetics Genom."},{"key":"10.1016\/j.cbi.2018.12.004_bib54","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.1016\/j.bmcl.2003.08.005","article-title":"Practical, asymmetric synthesis of 16-hydroxyeicosa-5(Z),8(Z), 11(Z),14(Z)-tetraenoic acid (16-HETE), an endogenous inhibitor of neutrophil activity","volume":"13","author":"Reddy","year":"2003","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.cbi.2018.12.004_bib55","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.bbalip.2014.10.008","article-title":"Biosynthesis, biological effects, and receptors of hydroxyeicosatetraenoic acids (HETEs) and oxoeicosatetraenoic acids (oxo-ETEs) derived from arachidonic acid","volume":"1851","author":"Powell","year":"2015","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.cbi.2018.12.004_bib56","doi-asserted-by":"crossref","first-page":"15720","DOI":"10.1021\/bi048312s","article-title":"Enantioselective substrate specificity of 15-lipoxygenase 1","volume":"43","author":"Ivanov","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.cbi.2018.12.004_bib57","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0006-2952(00)00345-2","article-title":"16(R)-hydroxy-5,8,11,14-eicosatetraenoic acid, a new arachidonate metabolite in human polymorphonuclear leukocytes","volume":"60","author":"Bednar","year":"2000","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2018.12.004_bib58","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1212\/WNL.49.5_Suppl_4.S20","article-title":"Antineutrophil strategies","volume":"49","author":"Bednar","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.cbi.2018.12.004_bib59","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1124\/mol.58.2.279","article-title":"CYP2C40, a unique arachidonic acid 16-hydroxylase, is the major CYP2C in murine intestinal tract","volume":"58","author":"Tsao","year":"2000","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.cbi.2018.12.004_bib60","doi-asserted-by":"crossref","first-page":"e0119087","DOI":"10.1371\/journal.pone.0119087","article-title":"Arachidonic and linoleic acid derivatives impact oocyte ICSI fertilization--a prospective analysis of follicular fluid and a matched oocyte in a \u201cone follicle--one retrieved oocyte--one resulting embryo\u201d investigational setting","volume":"10","author":"Ciepiela","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.cbi.2018.12.004_bib61","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1161\/HYPERTENSIONAHA.116.07834","article-title":"dietary flaxseed reduces central aortic blood pressure without cardiac involvement but through changes in plasma oxylipins","volume":"68","author":"Caligiuri","year":"2016","journal-title":"Hypertension (Dallas, Tex. 1979)"},{"key":"10.1016\/j.cbi.2018.12.004_bib62","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1097\/00006123-200012000-00029","article-title":"16(R)-hydroxyeicosatetraenoic acid, a novel cytochrome P450 product of arachidonic acid, suppresses activation of human polymorphonuclear leukocyte and reduces intracranial pressure in a rabbit model of thromboembolic stroke","volume":"47","author":"Bednar","year":"2000","journal-title":"Neurosurgery"},{"key":"10.1016\/j.cbi.2018.12.004_bib63","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1161\/01.HYP.25.4.854","article-title":"Identification of arachidonate P-450 metabolites in human platelet phospholipids","volume":"25","author":"Zhu","year":"1995","journal-title":"Hypertension (Dallas, Tex. 1979)"},{"key":"10.1016\/j.cbi.2018.12.004_bib64","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.prostaglandins.2015.09.003","article-title":"Metabolites of arachidonic acid and linoleic acid in early stages of non-alcoholic fatty liver disease--A pilot study","volume":"121","author":"Maciejewska","year":"2015","journal-title":"Prostag. Other Lipid Mediat."},{"key":"10.1016\/j.cbi.2018.12.004_bib65","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1038\/ki.1997.234","article-title":"Cytochrome P450-derived renal HETEs: storage and release","volume":"51","author":"Carroll","year":"1997","journal-title":"Kidney Int."},{"key":"10.1016\/j.cbi.2018.12.004_bib66","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1085\/jgp.106.4.727","article-title":"Effect of arachidonic acid on activity of the apical K+ channel in the thick ascending limb of the rat kidney","volume":"106","author":"Wang","year":"1995","journal-title":"J. Gen. Physiol."},{"key":"10.1016\/j.cbi.2018.12.004_bib67","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1139\/cjpp-2014-0136","article-title":"Acute arsenic treatment alters arachidonic acid and its associated metabolite levels in the brain of C57Bl\/6 mice","volume":"92","author":"Anwar-Mohamed","year":"2014","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.cbi.2018.12.004_bib68","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1038\/ijo.2016.117","article-title":"Vasoconstrictor eicosanoids and impaired microvascular function in inactive and insulin-resistant primates","volume":"40","author":"Chadderdon","year":"2016","journal-title":"Int. J. Obes. (Lond)."},{"key":"10.1016\/j.cbi.2018.12.004_bib69","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.cbi.2016.07.001","article-title":"Enantioselective inhibition of Cytochrome P450-mediated drug metabolism by a novel antithrombotic agent, S002-333: major effect on CYP2B6","volume":"256","author":"Bhateria","year":"2016","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2018.12.004_bib70","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1124\/dmd.115.067975","article-title":"Absorption differences between immediate-release dexmethylphenidate and dl-methylphenidate","volume":"44","author":"Patrick","year":"2016","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.cbi.2018.12.004_bib71","doi-asserted-by":"crossref","first-page":"188","DOI":"10.2174\/138920009787522188","article-title":"Stereoselectivity in drug metabolism: molecular mechanisms and analytical methods","volume":"10","author":"Campo","year":"2009","journal-title":"Curr. Drug Metabol."},{"key":"10.1016\/j.cbi.2018.12.004_bib72","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0021-9673(95)00465-3","article-title":"Importance of stereospecific bioanalytical monitoring in drug development","volume":"719","author":"Caldwell","year":"1996","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.cbi.2018.12.004_bib73","article-title":"S-enantiomer of 19-hydroxyeicosatetraenoic acid preferentially protects against angiotensin II-induced cardiac hypertrophy","volume":"118","author":"Shoieb","year":"2018","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.cbi.2018.12.004_bib74","article-title":"Differential properties of enantiomers of commercially available racemates","volume":"105","author":"Gulati","year":"2007","journal-title":"J. Indian Med. Assoc."},{"key":"10.1016\/j.cbi.2018.12.004_bib75","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1152\/physrev.00021.2011","article-title":"Epoxides and soluble epoxide hydrolase in cardiovascular physiology","volume":"92","author":"Imig","year":"2012","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.cbi.2018.12.004_bib76","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.taap.2012.09.007","article-title":"Elevated blood pressure in cytochrome P4501A1 knockout mice is associated with reduced vasodilation to omega-3 polyunsaturated fatty acids","volume":"264","author":"Agbor","year":"2012","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.cbi.2018.12.004_bib77","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.taap.2003.08.008","article-title":"Cardiac hypertrophy in aryl hydrocarbon receptor null mice is correlated with elevated angiotensin II, endothelin-1, and mean arterial blood pressure","volume":"193","author":"Lund","year":"2003","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.cbi.2018.12.004_bib78","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1258\/ebm.2010.009233","article-title":"Renal function and vasomotor activity in mice lacking the Cyp4a14 gene","volume":"235","author":"Fidelis","year":"2010","journal-title":"Exp. Biol. Med. (Maywood)."},{"key":"10.1016\/j.cbi.2018.12.004_bib79","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s10753-013-9809-6","article-title":"Altered inflammatory responses to Citrobacter rodentium infection, but not bacterial lipopolysaccharide, in mice lacking the Cyp4a10 or Cyp4a14 genes","volume":"37","author":"Nyagode","year":"2014","journal-title":"Inflammation"},{"key":"10.1016\/j.cbi.2018.12.004_bib80","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.toxlet.2008.10.018","article-title":"Relation of PON1 and CYP1A1 genetic polymorphisms to clinical findings in a cross-sectional study of a Greek rural population professionally exposed to pesticides","volume":"186","author":"Tsatsakis","year":"2009","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.cbi.2018.12.004_bib81","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1136\/jmg.2004.022012","article-title":"Genetic polymorphism of CYP1A2 increases the risk of myocardial infarction","volume":"41","author":"Cornelis","year":"2004","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.cbi.2018.12.004_bib82","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1097\/01.hjh.0000244944.34546.8e","article-title":"Association of a functional polymorphism in the CYP4A11 gene with systolic blood pressure in survivors of myocardial infarction","volume":"24","author":"Mayer","year":"2006","journal-title":"J. Hypertens."},{"key":"10.1016\/j.cbi.2018.12.004_bib83","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1681\/ASN.2008010063","article-title":"Association of a CYP4A11 variant and blood pressure in black men","volume":"19","author":"Gainer","year":"2008","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cbi.2018.12.004_bib84","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1097\/HJH.0b013e32834aa786","article-title":"CYP4A11 T8590C polymorphism, salt-sensitive hypertension, and renal blood flow","volume":"29","author":"Williams","year":"2011","journal-title":"J. Hypertens."},{"key":"10.1016\/j.cbi.2018.12.004_bib85","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0895-7061(97)00057-5","article-title":"Endothelium-derived hyperpolarizing factor: characterization as a cytochrome P450 1A-linked metabolite of arachidonic acid in perfused rat mesenteric prearteriolar bed","volume":"10","author":"Adeagbo","year":"1997","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.cbi.2018.12.004_bib86","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/0024-3205(95)00108-I","article-title":"Arachidonic acid metabolism modulates vasopressin-induced renal vasoconstriction","volume":"56","author":"Vazquez","year":"1995","journal-title":"Life Sci."},{"key":"10.1016\/j.cbi.2018.12.004_bib87","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/0003-9861(90)90340-5","article-title":"Possible involvement of arachidonic acid metabolites of cytochrome P450 monooxygenase pathway in vasopressin-stimulated glycogenolysis in isolated rat hepatocytes","volume":"280","author":"Yoshida","year":"1990","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.cbi.2018.12.004_bib88","series-title":"Methods and Products Related to 16-HETE Analogs","year":"1999"},{"key":"10.1016\/j.cbi.2018.12.004_bib89","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13293-016-0124-4","article-title":"Sex-dependent alteration of cardiac cytochrome P450 gene expression by doxorubicin in C57Bl\/6 mice","volume":"8","author":"Grant","year":"2017","journal-title":"Biol. Sex Differ."},{"key":"10.1016\/j.cbi.2018.12.004_bib90","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0031-6997(24)01340-1","article-title":"Role of pharmacokinetics and metabolism in drug discovery and development","volume":"49","author":"Lin","year":"1997","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.cbi.2018.12.004_bib91","doi-asserted-by":"crossref","first-page":"19881","DOI":"10.1073\/pnas.0809120105","article-title":"ERK-mediated regulation of leukotriene biosynthesis by androgens: a molecular basis for gender differences in inflammation and asthma","volume":"105","author":"Pergola","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.cbi.2018.12.004_bib92","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.prostaglandins.2011.06.006","article-title":"The role of 20-HETE in androgen-mediated hypertension","volume":"96","author":"Wu","year":"2011","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"10.1016\/j.cbi.2018.12.004_bib93","unstructured":"H. Singh, M.L. Schwartzman, Renal vascular cytochrome P450-derived eicosanoids in androgen-induced hypertension., Pharmacol. Rep. 60 (n.d.) 29\u201337. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18276983 (accessed November 23, 2018)."},{"key":"10.1016\/j.cbi.2018.12.004_bib94","first-page":"115","article-title":"Evidence for the effect of gender on activity of (S)-mephenytoin 4\u2019-hydroxylase (CYP2C19) in a Chinese population","volume":"7","author":"Xie","year":"1997","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.cbi.2018.12.004_bib95","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1124\/dmd.109.026963","article-title":"Regulation of human CYP2C18 and CYP2C19 in transgenic mice: influence of castration, testosterone, and growth hormone","volume":"37","author":"L\u00f6fgren","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.cbi.2018.12.004_bib96","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.phrs.2017.07.013","article-title":"Drug repurposing in cancer","volume":"124","author":"Sleire","year":"2017","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.cbi.2018.12.004_bib97","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2174\/1568010053586354","article-title":"Arachidonic acid signaling in pathogenesis of allergy: therapeutic implications","volume":"4","author":"Serrano-Mollar","year":"2005","journal-title":"Curr. Drug Targets - Inflamm. Allergy"},{"key":"10.1016\/j.cbi.2018.12.004_bib98","doi-asserted-by":"crossref","first-page":"3774","DOI":"10.1073\/pnas.76.8.3774","article-title":"Aspirin-like drugs interfere with arachidonate metabolism by inhibition of the 12-hydroperoxy-5,8,10,14-eicosatetraenoic acid peroxidase activity of the lipoxygenase pathway","volume":"76","author":"Siegel","year":"1979","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.cbi.2018.12.004_bib99","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/j.jacc.2017.08.037","article-title":"Antiplatelet agents for the treatment and prevention of coronary atherothrombosis","volume":"70","author":"Patrono","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.cbi.2018.12.004_bib100","first-page":"S691","article-title":"Update on aspirin in the treatment and prevention of cardiovascular disease","volume":"8","author":"Hennekens","year":"2002","journal-title":"Am. J. Manag. Care"},{"key":"10.1016\/j.cbi.2018.12.004_bib101","doi-asserted-by":"crossref","first-page":"719","DOI":"10.3389\/fimmu.2017.00719","article-title":"Toll-like receptor 4 inhibition improves oxidative stress and mitochondrial health in isoproterenol-induced cardiac hypertrophy in rats","volume":"8","author":"Katare","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cbi.2018.12.004_bib102","doi-asserted-by":"crossref","first-page":"5285","DOI":"10.1128\/AAC.00854-16","article-title":"Role of inflammatory and oxidative stress, cytochrome P450 2E1, and bile acid disturbance in rat liver injury induced by isoniazid and lipopolysaccharide cotreatment","volume":"60","author":"Hassan","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.cbi.2018.12.004_bib103","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/j.tiv.2014.05.014","article-title":"CYP2E1 induction leads to oxidative stress and cytotoxicity in glutathione-depleted cerebellar granule neurons","volume":"28","author":"Valencia-Olvera","year":"2014","journal-title":"Toxicol. Vitro"},{"key":"10.1016\/j.cbi.2018.12.004_bib104","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1067\/mcp.2003.14","article-title":"Isozyme-specific induction of low-dose aspirin on cytochrome P450 in healthy subjects","volume":"73","author":"Chen","year":"2003","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.cbi.2018.12.004_bib105","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/s11684-015-0421-z","article-title":"Acetyl salicylic acid attenuates cardiac hypertrophy through Wnt signaling","volume":"9","author":"Gitau","year":"2015","journal-title":"Front. Med."},{"key":"10.1016\/j.cbi.2018.12.004_bib106","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/1755-5922.12164","article-title":"Aspirin attenuates angiotensin II-induced cardiomyocyte hypertrophy by inhibiting the Ca(2+)\/calcineurin-NFAT signaling pathway","volume":"34","author":"Yin","year":"2016","journal-title":"Cardiovasc. Ther."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279718313152?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279718313152?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T13:53:03Z","timestamp":1757857983000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279718313152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":105,"alternative-id":["S0009279718313152"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2018.12.004","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Subterminal hydroxyeicosatetraenoic acids: Crucial lipid mediators in normal physiology and disease states","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2018.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}